(Q37958349)

English

Cost-effectiveness analysis of the early conversion of tacrolimus to mammalian target of rapamycin inhibitors in patients with renal transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Cost-effectiveness analysis of the early conversion of tacrolimus to mammalian target of rapamycin inhibitors in patients with renal transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

based on heuristic

inferred from title

author name string

O Gamboa

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

C Montero

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

L Mesa

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

C Benavides

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

A Reino

5

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

R E Torres

6

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

J S Castillo

7

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

language of work or name

0 references

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

3367-3376

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Renal disease in Colombia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Protocol conversion from a calcineurin inhibitor based therapy to sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Post-transplant renal function in the first year predicts long-term kidney transplant survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Arterial hypertension and renal allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Determining transition probabilities: confusion and suggestions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Malignancies in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Long-term kidney regraft survival from deceased donors: risk factors and outcomes in a single center

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Diabetes mellitus after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

The influence of acute rejection on long-term renal allograft survival: a comparison of living and cadaveric donor transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Influence of early graft function after renal transplantation and its impact on long-term graft and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Major effects of delayed graft function and cold ischaemia time on renal allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Impact of acute rejection episodes on long-term graft survival following simultaneous kidney-pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Patient mortality after graft failure reduces kidney transplant patient survival only in the long term: an "intention to treat" analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.09.092

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2011.09.092

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37958349&oldid=2088649817"